NASDAQ:NKTR

Nektar Therapeutics Stock Predictions

etoro logo Buy NKTR
*Your capital is at risk
$59.23
+0.670 (+1.14%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

NKTR Prediction Chart

NKTR Predictions History

Latest community submissions for NKTR.
Predictor Target Session Target Price Result Direction Accuracy Score
Chaser Chaser Pro
Jun 5, 2019 $33.25 -1.16% $33.64 X 98.84% 1
Chaser Chaser Pro
May 21, 2019 $31.76 -4.97% $33.42 X 95.03% 0
Chaser Chaser Pro
May 20, 2019 $31.27 -2.74% $32.15 X 97.26% 0
joe1234 joe1234 Pro
May 13, 2019 $33.59 +3.01% $32.61 X 96.99% 0
Apr 30, 2019 $32.01 -0.03% $32.02 X 99.97% 10
Chaser Chaser Pro
Apr 17, 2019 $33.90 +8.69% $31.19 X 91.31% 0
Chaser Chaser Pro
Apr 12, 2019 $35.98 +2.36% $35.15 X 97.64% 0
JS JS Pro
Jan 10, 2018 $64.98 -5.69% $68.90 X 94.30% 0
JS JS Pro
Jul 25, 2017 $22.65 -2.50% $23.23 X 97.50% 0
Victor..Li.8930 Victor..Li.8930 Merchant
Jul 25, 2017 $23.09 -0.60% $23.23 X 99.40% 3
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NKTR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NEKTAR THERAPEUTICS
Nektar Therapeutics
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE